BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11979373)

  • 1. Different patterns of 11q allelic losses in digestive endocrine tumors.
    D'adda T; Pizzi S; Azzoni C; Bottarelli L; Crafa P; Pasquali C; Davoli C; Corleto VD; Delle Fave G; Bordi C
    Hum Pathol; 2002 Mar; 33(3):322-9. PubMed ID: 11979373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
    Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
    Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
    Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
    J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.
    Kytölä S; Höög A; Nord B; Cedermark B; Frisk T; Larsson C; Kjellman M
    Am J Pathol; 2001 May; 158(5):1803-8. PubMed ID: 11337378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.
    Dong Q; Debelenko LV; Chandrasekharappa SC; Emmert-Buck MR; Zhuang Z; Guru SC; Manickam P; Skarulis M; Lubensky IA; Liotta LA; Collins FS; Marx SJ; Spiegel AM
    J Clin Endocrinol Metab; 1997 May; 82(5):1416-20. PubMed ID: 9141526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity on chromosome arm 11q in lung carcinoids.
    Petzmann S; Ullmann R; Klemen H; Renner H; Popper HH
    Hum Pathol; 2001 Mar; 32(3):333-8. PubMed ID: 11274644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung.
    Debelenko LV; Brambilla E; Agarwal SK; Swalwell JI; Kester MB; Lubensky IA; Zhuang Z; Guru SC; Manickam P; Olufemi SE; Chandrasekharappa SC; Crabtree JS; Kim YS; Heppner C; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Collins FS; Travis WD; Emmert-Buck MR
    Hum Mol Genet; 1997 Dec; 6(13):2285-90. PubMed ID: 9361035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.
    Hessman O; Skogseid B; Westin G; Akerström G
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1355-61. PubMed ID: 11238532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
    Görtz B; Roth J; Krähenmann A; de Krijger RR; Muletta-Feurer S; Rütimann K; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
    Am J Pathol; 1999 Feb; 154(2):429-36. PubMed ID: 10027401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
    Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
    Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
    Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
    Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
    Pourani J; Kaserer K; Pfragner R
    Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
    Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
    Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus.
    Eubanks PJ; Sawicki MP; Samara GJ; Wan YJ; Gatti RA; Hurwitz M; Passaro E
    Am J Surg; 1997 Jun; 173(6):518-20. PubMed ID: 9207166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
    D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
    Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.
    Rigaud G; Missiaglia E; Moore PS; Zamboni G; Falconi M; Talamini G; Pesci A; Baron A; Lissandrini D; Rindi G; Grigolato P; Pederzoli P; Scarpa A
    Cancer Res; 2001 Jan; 61(1):285-92. PubMed ID: 11196176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
    Guo SS; Wu AY; Sawicki MP
    World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.
    Emmert-Buck MR; Lubensky IA; Dong Q; Manickam P; Guru SC; Kester MB; Olufemi SE; Agarwal S; Burns AL; Spiegel AM; Collins FS; Marx SJ; Zhuang Z; Liotta LA; Chandrasekharappa SC; Debelenko LV
    Cancer Res; 1997 May; 57(10):1855-8. PubMed ID: 9157974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.